Rankings Pricing

Carna Biosciences, Inc.JP:4572

Market cap

¥6.9B

P/E ratio

-3.2x

Summary Financials History Segments Ownership Workforce

Income statement Balance sheet Cash flow Other

	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	-	627	1,625	2,161	1,856	1,355	4,915	4,299	3,818	3,379	2,889	2,108
Inventories	-	94	91	87	83	75	63	66	73	84	94	108
Total current assets	-	908	1,996	2,493	2,134	1,672	5,275	4,708	5,318	4,104	4,191	2,738
Property, plant and equipment, net	-	53	37	35	20	19	30	53	52	100	105	-
Marketable securities, non-current	-	241	286	-	-	-	-	-	-	-	-	-
Total non-current assets	-	314	342	74	56	99	102	127	114	162	158	34
Total assets	-	1,221	2,338	2,566	2,190	1,770	5,377	4,835	5,433	4,266	4,350	2,772
Long-term debt, current	-	39	65	142	154	205	271	162	211	120	120	20
Total current liabilities	-	196	236	271	342	400	1,055	727	775	436	376	223
Long-term debt, non-current	-	122	148	355	298	338	342	180	268	148	28	8
Total non-current liabilities	-	196	231	556	471	482	468	284	342	188	96	74
Total liabilities	-	391	467	827	812	883	1,523	1,011	1,117	625	472	297
Common stock and paid-in capital	-	4,072	4,620	4,904	5,271	6,001	8,133	4,869	5,865	6,516	7,904	8,647
Retained earnings	-	-3,336	-2,880	-3,170	-3,907	-5,117	-4,289	-1,038	-1,573	-2,922	-4,075	-6,254
Stockholders' equity	1,598	830	1,871	1,739	1,378	887	3,854	3,824	4,316	3,642	3,878	2,475

Raw aggregated data